Entera Bio Ltd. (ENTX) Q4 2021 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Entera Bio Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.049 -- 00:00:05.052 Greetings and welcome to the Interrobio fourth quarter and year-end 2021 earnings 00:00:05.052 -- 00:00:09.374 call. At this time, all participants are in a listen-only mode. 00:00:09.374 -- 00:00:12.796 A question and answer session will follow the formal presentation. 00:00:12.796 -- 00:00:16.498 If anyone should require operator assistance during the conference, please press star 00:00:16.498 -- 00:00:21.640 zero on your telephone keypad. As a reminder, this conference is being recorded. 00:00:21.640 -- 00:00:25.242 I would now like to turn the call over to Ramesh Ratan, Chief Financial Officer. 00:00:25.242 -- 00:00:27.463 Thank you. You may begin. 00:00:27.463 -- 00:00:32.730 Good morning and welcome to the call. Joining me on today's call are Scott Johns, 00:00:32.730 -- 00:00:37.774 our CEO, Arthur Santora, our chief medical officer, and Philip Schwartz, 00:00:37.774 -- 00:00:43.118 our founder and president of R&D. A press release announcing NTERRA's 00:00:43.118 -- 00:00:48.502 financial and operating results for the full year ended December 31, 2021, was issued 00:00:48.502 -- 00:00:53.706 this morning. For those of you who have not yet seen it, it's available on the investor 00:00:53.706 -- 00:00:57.808 section of our website, www.nterrabio.com. 00:00:59.901 -- 00:01:04.943 On our call this morning, we will share with you a business update and review of our 00:01:04.943 -- 00:01:09.804 financial results, which will be followed by a question and answer session. 00:01:09.804 -- 00:01:14.566 Before we begin our prepared remarks, I'd like to remind you that various statements 00:01:14.566 -- 00:01:19.547 we make during this call about the company's future results of operation and financial 00:01:19.547 -- 00:01:25.189 positi...